PT3285784T - Método para preparar uma amostra de microbiota fecal - Google Patents
Método para preparar uma amostra de microbiota fecalInfo
- Publication number
- PT3285784T PT3285784T PT167234335T PT16723433T PT3285784T PT 3285784 T PT3285784 T PT 3285784T PT 167234335 T PT167234335 T PT 167234335T PT 16723433 T PT16723433 T PT 16723433T PT 3285784 T PT3285784 T PT 3285784T
- Authority
- PT
- Portugal
- Prior art keywords
- preparing
- fecal microbiota
- microbiota sample
- sample
- fecal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1553716A FR3035328B1 (fr) | 2015-04-24 | 2015-04-24 | Procede de preparation d'un echantillon de microbiote fecal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3285784T true PT3285784T (pt) | 2020-08-31 |
Family
ID=53794336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT167234335T PT3285784T (pt) | 2015-04-24 | 2016-04-22 | Método para preparar uma amostra de microbiota fecal |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10980839B2 (pt) |
| EP (1) | EP3285784B1 (pt) |
| JP (1) | JP6858747B2 (pt) |
| CN (1) | CN107530280B (pt) |
| AU (1) | AU2016252209B2 (pt) |
| CA (1) | CA2983192A1 (pt) |
| DK (1) | DK3285784T3 (pt) |
| ES (1) | ES2812854T3 (pt) |
| FR (1) | FR3035328B1 (pt) |
| HU (1) | HUE050430T2 (pt) |
| IL (1) | IL255100B (pt) |
| PL (1) | PL3285784T3 (pt) |
| PT (1) | PT3285784T (pt) |
| WO (1) | WO2016170285A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3045384B1 (fr) * | 2015-12-18 | 2020-02-07 | Institut National De La Recherche Agronomique | Composition lyophilisee pour la conservation de microbiote dans son ecosysteme |
| US20180030403A1 (en) | 2016-07-28 | 2018-02-01 | Bobban Subhadra | Devices, systems and methods for the production of humanized gut commensal microbiota |
| FR3062063B1 (fr) | 2017-01-26 | 2019-04-19 | Centre National De La Recherche Scientifique | Microbiote fecal pour traiter des patients subissant une greffe de cellules souches hematopoietiques |
| JP2020521760A (ja) * | 2017-05-26 | 2020-07-27 | クレストヴォ・ホールディングス・エルエルシー | 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法 |
| EP3485879A1 (en) | 2017-11-17 | 2019-05-22 | Maat Pharma | Pharmaceutical oral formulation comrpsing bacteria |
| FR3078627B1 (fr) * | 2018-03-09 | 2020-11-13 | Maat Pharma | Procedure de collecte de selles et procede de preparation d'un echantillon pour transplantation de microbiote fecal |
| EP3597202A1 (en) | 2018-07-20 | 2020-01-22 | Maat Pharma | Fecal microbiota composition, for use in reducing treatment-induced inflammation |
| CN109010380A (zh) * | 2018-08-21 | 2018-12-18 | 卓源健康科技有限公司 | 一种粪菌移植临床治疗中的肠道菌群制剂的工艺 |
| WO2020247846A1 (en) * | 2019-06-07 | 2020-12-10 | Anaerobe Systems | Microbial collection formulations, devices and systems |
| EP3895716A1 (en) | 2020-04-17 | 2021-10-20 | Maat Pharma | Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients |
| RU2745125C1 (ru) * | 2020-07-15 | 2021-03-22 | Общество с ограниченной ответственностью «Байкальский центр биомедицинских исследований» (ООО «БайкалБиоМед») | Устройство и способ подготовки в анаэробных условиях донорской фекальной микробиоты к трансплантации |
| CN112226369A (zh) * | 2020-10-23 | 2021-01-15 | 重庆浦洛通基因医学研究院有限公司 | 一种肠道菌群保存液及制备方法 |
| CN116615527A (zh) | 2020-12-23 | 2023-08-18 | 玛阿特制药公司 | 扩大复合微生物群落的方法 |
| RU2761047C1 (ru) * | 2021-03-10 | 2021-12-02 | Федеральное государственное бюджетное научное учреждение "Иркутский научный центр хирургии и травматологии" | Устройство для подготовки донорского фекального материала к трансплантации |
| EP4086337A1 (en) | 2021-05-06 | 2022-11-09 | Maat Pharma | Method of predicting and then producing a mix of microbiota samples |
| EP4369344A1 (en) | 2022-11-08 | 2024-05-15 | Maat Pharma | Determination of microbiota samples to produce a target mix product and prediction of mixes |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| KR20100088894A (ko) * | 2009-02-02 | 2010-08-11 | 에이엠바이오 (주) | 멤브레인 생물반응기를 이용한 고농도 유산균의 생산방법 및 유산균 동결건조 분말의 제조방법 |
| ES2425385T3 (es) * | 2009-04-30 | 2013-10-15 | Actogenix N.V. | Crioprotectores para la liofilización de las bacterias de ácido láctico |
| KR101799983B1 (ko) * | 2009-05-26 | 2017-12-20 | 어드밴스드 바이오뉴트리션 코프. | 생물학적 활성 미생물 및/또는 생활성 물질을 포함하는 안정한 건식분말 조성물 및 제조 방법 |
| US7888062B1 (en) * | 2010-02-01 | 2011-02-15 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
| WO2011122949A1 (en) | 2010-04-02 | 2011-10-06 | Antonius Henricus Petrus Bosch | Auxiliary device for receiving fecal matter |
| EP3311825A1 (en) | 2010-08-04 | 2018-04-25 | Thomas Julius Borody | Compositions for fecal floral transplantation and methods for making and using them |
| WO2014152484A1 (en) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
| ES2636439T3 (es) * | 2011-03-09 | 2017-10-05 | Regents Of The University Of Minnesota | Composiciones y métodos para el trasplante de microbiota de colon |
| CN103160489B (zh) * | 2011-12-12 | 2015-01-14 | 润盈生物工程（上海）有限公司 | 日化微胶囊益生菌的制备方法 |
| WO2014029758A1 (en) * | 2012-08-20 | 2014-02-27 | Chr. Hansen A/S | Method for optimizing a process for freeze drying a bacteria-containing concentrate |
| CN102827796B (zh) * | 2012-09-03 | 2013-10-30 | 江南大学 | 一种具有排镉功能的植物乳杆菌及其用途 |
| EP2922555A4 (en) | 2012-11-26 | 2016-06-15 | Borody Thomas J | COMPOSITIONS FOR THE RESTORATION OF AN FECAL MICROBIOTE AND METHODS OF MAKING AND USING THEM |
| KR102222273B1 (ko) | 2013-02-04 | 2021-03-08 | 세레스 테라퓨틱스, 인코포레이티드 | 조성물 및 방법 |
| EP2951283A4 (en) | 2013-02-04 | 2017-01-25 | Seres Therapeutics, Inc. | Compositions and methods |
| AU2014262125B2 (en) | 2013-04-30 | 2020-02-13 | Thomas Julius Borody | Compositions and methods for treating microbiota-related psychotropic conditions and diseases |
| CN105473152A (zh) * | 2013-06-05 | 2016-04-06 | 雷柏奥提斯有限公司 | 菌群恢复疗法（mrt）、组合物和制造方法 |
| US20150037285A1 (en) * | 2013-07-03 | 2015-02-05 | New York University | Methods for efficient transfer of viable and bioactive microbiota |
| BR112017026586B1 (pt) | 2015-06-09 | 2021-11-03 | Rebiotix, Inc. | Composições de terapia de restauração de microbiota (mrt) e métodos de fabricação |
| EP3368050A1 (en) | 2015-10-26 | 2018-09-05 | Crestovo Holdings LLC | Compositions and methods for fecal microbiota-related therapy |
-
2015
- 2015-04-24 FR FR1553716A patent/FR3035328B1/fr active Active
-
2016
- 2016-04-22 JP JP2018506488A patent/JP6858747B2/ja active Active
- 2016-04-22 PL PL16723433T patent/PL3285784T3/pl unknown
- 2016-04-22 PT PT167234335T patent/PT3285784T/pt unknown
- 2016-04-22 AU AU2016252209A patent/AU2016252209B2/en active Active
- 2016-04-22 DK DK16723433.5T patent/DK3285784T3/da active
- 2016-04-22 ES ES16723433T patent/ES2812854T3/es active Active
- 2016-04-22 IL IL255100A patent/IL255100B/en unknown
- 2016-04-22 CN CN201680023630.8A patent/CN107530280B/zh active Active
- 2016-04-22 HU HUE16723433A patent/HUE050430T2/hu unknown
- 2016-04-22 US US15/568,838 patent/US10980839B2/en active Active
- 2016-04-22 EP EP16723433.5A patent/EP3285784B1/fr active Active
- 2016-04-22 WO PCT/FR2016/050958 patent/WO2016170285A1/fr active Application Filing
- 2016-04-22 CA CA2983192A patent/CA2983192A1/fr active Pending
-
2021
- 2021-02-04 US US17/167,573 patent/US20210154239A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL3285784T3 (pl) | 2020-11-16 |
| EP3285784B1 (fr) | 2020-07-08 |
| CN107530280A (zh) | 2018-01-02 |
| FR3035328B1 (fr) | 2019-08-23 |
| JP2018514228A (ja) | 2018-06-07 |
| US20210154239A1 (en) | 2021-05-27 |
| IL255100B (en) | 2022-09-01 |
| FR3035328A1 (fr) | 2016-10-28 |
| AU2016252209B2 (en) | 2022-03-03 |
| US20180099012A1 (en) | 2018-04-12 |
| ES2812854T3 (es) | 2021-03-18 |
| HUE050430T2 (hu) | 2020-12-28 |
| CN107530280B (zh) | 2021-10-26 |
| US10980839B2 (en) | 2021-04-20 |
| JP6858747B2 (ja) | 2021-04-14 |
| EP3285784A1 (fr) | 2018-02-28 |
| AU2016252209A1 (en) | 2017-12-07 |
| WO2016170285A1 (fr) | 2016-10-27 |
| CA2983192A1 (fr) | 2016-10-27 |
| IL255100A0 (en) | 2017-12-31 |
| DK3285784T3 (da) | 2020-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3285784T3 (pl) | Sposób wytwarzania próbki mikrobioty kałowej | |
| HK1252952A1 (zh) | 複雜樣本類型的樣本製備 | |
| GB201403096D0 (en) | Sample preparation method | |
| GB201402318D0 (en) | Method for materials analysis | |
| ZA201606844B (en) | Method for preparing amg 416 | |
| PT3389679T (pt) | Método para liofilização de uma amostra de microbiota fecal | |
| RS62495B1 (sr) | Postupak za ispitivanje sigurnosnog dokumenta | |
| ZA201608367B (en) | Method for methylation analysis | |
| PT3196196T (pt) | Método para a preparação de calcobutrol | |
| EP2998732C0 (en) | ANALYSIS METHODS | |
| ZA201608777B (en) | Method for preparing methyl mercaptan | |
| HUE053440T2 (hu) | Embrió-mintavételezõ eljárás | |
| GB201507437D0 (en) | Method for preparing a sorbent | |
| EP3198064A4 (en) | Methods for sample preparation | |
| EP3217173A4 (en) | Method for detecting disease | |
| GB201519087D0 (en) | Method for adaption | |
| ZA201903463B (en) | Method for preparing hexadecahydropyrene | |
| EP3190190A4 (en) | Method for diagnosing fibromyalgia using micrornas | |
| EP3128328A4 (en) | Method for analyzing lipoproteins | |
| GB201419172D0 (en) | Method for cell sampling | |
| AU2014902155A0 (en) | Method for Methylation Analysis | |
| GB201408764D0 (en) | Improved culture method for organoids | |
| GB201412041D0 (en) | Method for preparing a sorbent | |
| GB201409660D0 (en) | Method for preparing a sorbent | |
| AU2014902582A0 (en) | Method for tomographic reconstuction of a sample |